Cargando…
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
Novel therapeutics are required for improving the management of chronic inflammatory diseases. Aptamers are single-stranded RNA or DNA molecules that have recently shown utility in a clinical setting, as they can specifically neutralize biomedically relevant proteins, particularly cell surface and e...
Autores principales: | Mor-Vaknin, Nirit, Saha, Anjan, Legendre, Maureen, Carmona-Rivera, Carmelo, Amin, M Asif, Rabquer, Bradley J., Gonzales-Hernandez, Marta J., Jorns, Julie, Mohan, Smriti, Yalavarthi, Srilakshmi, Pai, Dave A., Angevine, Kristine, Almburg, Shelley J., Knight, Jason S., Adams, Barbara S., Koch, Alisa E., Fox, David A., Engelke, David R., Kaplan, Mariana J., Markovitz, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303823/ https://www.ncbi.nlm.nih.gov/pubmed/28165452 http://dx.doi.org/10.1038/ncomms14252 |
Ejemplares similares
-
DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling
por: Capitano, Maegan L., et al.
Publicado: (2022) -
The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018) -
High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2014) -
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
por: Mor‐Vaknin, Nirit, et al.
Publicado: (2018) -
Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design
por: Dai, Lijun, et al.
Publicado: (2022)